
Fact Check Analysis: FDA expands approval of Moderna’s RSV vaccine to some adults under age 60
Introduction The recent article from ABC News focuses on the FDA’s expansion of Moderna’s respiratory syncytial virus (RSV) vaccine approval to include certain adults under age 60. A user flagged